中药多靶点干预代谢综合征血管内皮损伤研究进展

doi:10.19803/j.1672-8629.20220256

摘要/Abstract

摘要： 代谢综合征（metabolic syndrome, MS）是一组代谢异常聚集发病的临床症候群,发病机制复杂,不及时干预可导致动脉粥样硬化等心脑血管疾病,血管内皮损伤是心脑血管疾病的早期预测因子和主要病理基础。目前西医治疗以针对各组分进行降糖、降脂、降压和抗凝治疗为主,许多药物存在明显的使用禁忌,联合用药存在药物相互作用,可能加重药品不良反应。中医药在整体观念和辨证论治理论指导下,干预MS血管内皮损伤具有多途径、多靶点、作用持久、副作用小的特点。本文对中药治疗MS血管内皮损伤的作用机制进行综述,以期为中医药防治MS血管内皮损伤提供理论依据。

关键词: 代谢综合征, 血管内皮损伤, 中药, 多靶点, 药品不良反应

Abstract: Metabolic syndrome（MS）is a cluster of clinical syndromes of multiple metabolic disorders with complex pathogenesis. It can develop into atherosclerosis and serious cardio-cerebrovascular diseases if quick intervention is impossible. Vascular endothelial injury is an early predictor and the main pathological basis of MS. Western medicine focuses on hypoglycemic, lipid-lowering and hypotensive treatments, so many of these drugs have obvious contraindications, and drug interactions occur in combined medications, which is likely to aggravate adverse drug reactions. Under the guidance of holistic concepts and treatments based on syndrome differentiation theories, traditional Chinese medicine is characterized by multi-component and multiple-target properties, long-lasting efficacy and smaller side effects in the intervention of vascular endothelial injury of MS. This article summarizes the research progress in Chinese herbs in the treatment of vascular endothelial injury in order to provide data for the prevention and treatment of MS-related vascular endothelial injury by TCM.

Key words: metabolic syndrome, vascular endothelial injury, traditional Chinese medicine, multi-target, adverse drug reaction

中图分类号:

R994.11

徐帅, 张玲, 赵玉清, 杨一点, 卞昊宇, 张立平. 中药多靶点干预代谢综合征血管内皮损伤研究进展[J]. 中国药物警戒, 2023, 20(3): 353-359.

XU Shuai, ZHANG Ling, ZHAO Yuqing, YANG Yidian, BIAN Haoyu, ZHANG Liping. Advances in multi-target intervention in vascular endothelial injury in metabolic syndrome by traditional Chinese medicine[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 353-359.

参考文献

[1] GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age- sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013BD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age- sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013[J]. Lancet, 2015, 385(9963): 117-171.
[2] XU S, ILYAS I, LITTLE PJ, et al.Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies[J]. Pharmacol Rev, 2021, 73(3): 924-967.
[3] XIANG YF, SUN H, CHEN Y, et al.Medication safety and combined medication in patients with type 2 diabetes mellitus[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2022, 19(3): 313-316.
[4] WANG B, ZHANG J, LU Y, et al.Chaiqi decoction alleviates vascular endothelial injury by downregulating the inflammatory response in apoe-model mice[J]. Evid Based Complement Alternat Med, 2021, 2021: 9415819.
[5] LI DP.Medicine law analysis and meta analysis of traditional Chinese medicine in treating metabolic syndrome[D]. Jinan University(暨南大学), 2017.
[6] WANG HT, HE J.Huangdi’s Internal Classic·Plain Questions In Vernacular(素问·奇病论)[M]. Beijing: People’s Medical Publishing House, 2014: 188.
[7] WANG HT, HE J.Huangdi’s Internal Classic·Miraculous Pivot In Vernacular(灵枢·卫气失常)[M]. Beijing: People?s Medical Publishing House, 2014: 222.
[8] CHEN SG.Orthodox Manual of External Medicine(外科正宗)[M]. Beijing: People’s Medical Publishing House, 2007: 97.
[9] SAMSAMSHARIAT SZA, SAKHAEI F,SALEHIZADEH L,et al.Relationship between resistin,endothelin-1,and flow-mediated dilation in patient with and without metabolic syndrome[J]. Adv Biomed Res, 2019, 8: 16-22.
[10] IDRIS-KHODJA N, OUERD S, MIAN MOR, et al.Endothelin-1 overexpression exaggerates diabetes-induced endothelial dysfunction by altering oxidative stress[J]. Am J Hypertens, 2016, 29(11): 1245-1251.
[11] HERMANN M, FLAMMER A, LÜSCHER TF. Nitric oxide in hypertension[J]. J Clin Hypertens, 2006, 8(12 Suppl 4) : 17-29.
[12] WILCOX CS, WANG C, WANG D.Endothelin-1-induced microvascular ros and contractility in angiotensin-ii-infused mice depend on COX and TP receptors[J]. Antioxidants (Basel), 2019, 8(6): 193.
[13] LI DJ, CHU XY, LI J, et al.Regulation of puerarin on vasoactive factors in patients with metabolic syndrome[J].Journal of Pharmaceutical Research(药学研究), 2017, 36(08): 481-482,493.
[14] MA XG, SUN SY.Clinical effects of heat-clearing turbidity-lowering prescription combined with atorvastatin in treating T2DM complicated with MS and its influence on CK-MB and SHBG[J]. Western Journal of Traditional Chinese Medicine(西部中医药), 2021, 34(7): 102-105.
[15] WANG YY, LA XJ, ZHANG DW, et al.Influence of Shuang Qing Ping Hua Decoction on blood pressure, insulin resistance, RAS system and vascular endothelial function in rats with metabolic syndrome[J]. Modern Journal of Integrated Traditional Chinese and Western Medicine(现代中西医结合杂志), 2021, 30(20): 2172-2178.
[16] CHEN X, PANG S, LIN J, et al.Allicin prevents oxidized low-density lipoprotein-induced endothelial cell injury by inhibiting apoptosis and oxidative stress pathway[J]. BMC Complement Altern Med, 2016, 16: 133.
[17] DING R, YIN YL, JIANG LH.Reactive oxygen species-induced TRPM2-mediated Ca²+ signalling in endothelial cells[J]. Antioxidants (Basel), 2021, 10(5): 718.
[18] BARVITENKO N, SKVERCHINSKAYA E, LAWEN A, et al.pleiotropic and potentially beneficial effects of reactive oxygen species on the intracellular signaling pathways in endothelial cells[J]. Antioxidants (Basel), 2021, 10(6): 904.
[19] BUGGER H, ABEL ED.Molecular mechanisms of diabetic cardiomyopathy[J]. Diabetologia, 2014, 57(4): 660-671.
[20] WEI Y, DONG F, XU YL, et al.treatment of senile metabolic syndrome with Xiezhuo Tongyu prescription[J]. China Journal of Chinese Medicine(中医学报), 2020, 35(9): 1986-1990.
[21] YU Y, ZHAO DY, WANG YJ, et al.Antioxidant mechanism of Liuwei Dihuang Wan containing serum on human umbilical vein endothelial cells induced by palmitic acid[J]. Chinese Journal of Diabetes Mellitus(中国老年学杂志), 2014, 34(10): 2794-2796.
[22] YU Y, LI Y, LIN YH.Effects of Liuwei Dihuang Wan on oxidative stress injury of human umbilical vein endothelial cells with insulin resistance[J]. Chinese Journal of Diabetes Mellitus(中国老年学杂志), 2018, 38(21): 5285-5287.
[23] MEZA CA, LA FAVOR JD, KIM DH, et al.Endothelial dysfunction: is there a hyperglycemia-induced imbalance of NOX and NOS?[J]. Int J Mol Sci, 2019, 20(15): 3775.
[24] DIMMELER S, FLEMING I, FISSLTHALER B, et al.Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation[J]. Nature, 1999, 399(6736): 601-605.
[25] REN H, MU J, MA J, et al.Selenium inhibits homocysteine-induced endothelial dysfunction and apoptosis via activation of AKT[J].Cell Physiol Biochem, 2016, 38(3):871-882.
[26] JIANG ZY, LIN YW, CLEMONT A, et al.Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats[J]. J Clin Invest, 1999, 104(4): 447-457.
[27] KIM JA, MONTAGNANI M, KOH KK, et al.Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms[J]. Circulation, 2006, 113(15): 1888-1904.
[28] MUNIYAPPA R, CHEN H, MONTAGNANI M, et al.Endothelial dysfunction due to selective insulin resistance in vascular endothelium: insights from mechanistic modeling[J]. Am J Physiol Endocrinol Metab, 2020, 319(3): E629-E646.
[29] MAIDA CD, DAIDONE M, PACINELLA G, et al.Diabetes and ischemic stroke: an old and new relationship an overview of the close interaction between these diseases[J]. Int J Mol Sci, 2022, 23(4): 2397.
[30] KNAPP M, TU X, WU R.Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy[J]. Acta Pharmacol Sin, 2019,40(1):1-8.
[31] DAI ZQ, LU H, SHEN ZB, et al. Effect of Jianpi Qinghua Decoction on improving insulin resistance and circulating blood ace, ACE2 and Ang Ⅱ in elderly patients with metabolic syndrome[J/OL]. Journal of Liaoning University of Traditional Chinese Medicine.(2022-02-08)[2022-03-30]. http://kns.cnki.net/kcms/detail/21. 1543. r. 20220208. 1924. 008.html.
[32] LIU L, YANG YG, ZOU GL, et al.Effects of modified Huanglianwendan decoction on cardiovascular risk factors in patients with metabolic syndrome complicated with type 2 diabetes mellitus with phlegm-heat interaction[J]. China Medicine(中国医药),2021,16(10):1562-1566.
[33] YU BW, PAN XJ, CHEN JDX, et al.Effect of astragalus polysaccharides on glucose and lipid metabolism in diabetic atherosclerosis rats and vascular endothelial protection mechanism[J]. Journal of Zhejiang Chinese Medical University(浙江中医药大学学报), 2021, 45(5): 447-453.
[34] MAO ZJ, ZHANG X, ZHANG L, et al.Yunpi Huoxue Sanjie Decoction inhibited vascular endothelial injury of type 2 diabetic rats by regulating PI3K/Akt/eNOS pathway[J]. China Journal of Traditional Chinese Medicine and Pharmacy(中华中医药杂志), 2020, 35(9): 4672-4675.
[35] MIAO P, RUIQING T, YANRONG L, et al.Pyroptosis: A possible link between obesity-related inflammation and inflammatory diseases[J]. J Cell Physiol, 2022, 237(2): 1245-1265.
[36] CATURANO A, GALIERO R, PAFUNDI PC, et al.Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence[J]. Diabetes Res Clin Pract, 2021, 178: 108959.
[37] LI W, ZHANG D, YUAN W, et al.Humanin ameliorates free fatty acid-induced endothelial inflammation by suppressing the NLRP3 inflammasome[J]. ACS Omega, 2020, 5(35): 22039-22045.
[38] XING JH, LI R, GAO YQ, et al.NLRP3 inflammasome mediate palmitate-induced endothelial dysfunction[J]. Life Sci, 2019, 239: 116882.
[39] TRPKOVIC A, RESANOVIC I, STANIMIROVIC J, et al.Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases[J]. Crit Rev Clin Lab Sci, 2015, 52(2): 70-85.
[40] PIRILLO A, NORATA GD, CATAPANO AL.LOX-1, OxLDL, and atherosclerosis[J]. Mediators Inflamm. 2013, 2013: 152786.
[41] TSAI KL, HUNG CH, CHAN SH, et al.Baicalein protects against oxLDL-caused oxidative stress and inflammation by modulation of AMPK-alpha[J]. Oncotarget,2016,7(45): 72458-72468.
[42] SUN HJ, XU DY, SUN YX, et al.CO-releasing molecules-2 attenuates ox-LDL-induced injury in HUVECs by ameliorating mitochondrial function and inhibiting Wnt/β-catenin pathway[J]. Biochem Biophys Res Commun,2017, 490(3): 629-635.
[43] ZHANG GQ, TAO YK, BAI YP, et al.Inhibitory effects of simvastatin on oxidized low-density lipoprotein-induced endoplasmic reticulum stress and apoptosis in vascular endothelial cells[J]. Chin Med J (Engl), 2018, 131(8): 950-955.
[44] HUANG ZY, CHEN G, LEI HW.Clinical research of Jinkuishenqiwan recipe on type 2 diabetes mellitus coincidence hyperlipemia[J]. Chinese Archives of Traditional Chinese Medicine(中华中医药学刊), 2010, 28(11): 2457-2459.
[45] LIU XX, LI XJ, GONG CJ, et al.Effects of compound Yitangkang combined with prostaglandin E1 on vascular endothelial function, FGF-21 and free fatty acid level in patients with type 2 diabetes mellitus with syndrome of deficiency of both qi and Yin and syndrome of phlegm and blood stasis[J]. Chinese Journal of Basic Medicine in Traditional Chinese Medicine(中国中医基础医学杂志), 2019, 25(12): 1693-1696.
[46] SONG J, HU YQ, LIU J, et al.Astragalus polysaccharides protects against free fatty acid-induced human vascular endothelial cell dysfunction via AMPK-eNOS pathway[J]. Chinese Journal of Pathophysiology(中国病理生理杂志),2015, 31(7): 1305-1308, 1314.
[47] LIU L, CHAI ZY, DIAO YH, et al.Protective effect of Angelica Sinensis Polysaccharide on oxidized low density lipoprotein induced vascular endothelial cells injury[J]. The Chinese Journal of Clinical Pharmacology(中国临床药理学杂志), 2020, 36(7): 818-821.
[48] JING W, WU HX, CHAI Y.Protective effect of Buyang Huanwu Tang on human umbilical vascular endothelial cells injured by oxidized low density lipoprotein[J]. Chinese Journal of Experimental Traditional Medical Formulae(中国实验方剂学杂志), 2017, 23(3): 128-133.
[49] WANG GF, LU F, ZHAO X, et al.Protective effect of ligustrazine on oxidized LDL-induced injury of vascular endothelial cells[J]. Chinese Journal of Geriatric Heart Brain and Vessel Diseases(中华老年心脑血管病杂志), 2012, 14(3): 306-309.
[50] DU PLOOY CS, MARTHA CORNELIA MELS C, HUISMAN HW, et al. The association of endothelin-1 with markers of oxidative stress in a biethnic South African cohort: the SABPA study[J]. Hypertens Res, 2017, 40(2): 189-195.
[51] YU XH, ZHENG XL, TANG CK.Nuclear factor-κB activation as a pathological mechanism of lipid metabolism and atherosclerosis[J]. Adv Clin Chem,2015, 70:1-30.
[52] SURYAVANSHI SV, KULKARNI YA.NF-κβ: a potential target in the management of vascular complications of diabetes[J]. Front Pharmacol, 2017, 8: 798.
[53] AHMED HA, ABDELAZIZ SAA, ADEL AM,et al.Association of metabolic syndrome components with alterations in oxidative stress and cytokines expression[J]. Journal of Taibah University for Science, 2021, 15(1): 928-940.
[54] DAI CS, GAO YB, LI GS, et al.Effect of Qingfei Xiegantang on chronic inflammation and endothelial function with metabolic syndrome[J]. Chinese Journal of Experimental Traditional Medical Formulae(中国实验方剂学杂志), 2021, 27(5): 105-110.
[55] TAN SX, LI M.Effect of Silibinin Capsules on metabolic index and vascular endothelial function in patients with metabolic syndrome[J]. China Medical Herald(中国医药导报), 2020, 17(15): 131-134.
[56] GIULIANI A, CIRILLI I, PRATTICHIZZO F, et al.The mitomiR/Bcl-2 axis affects mitochondrial function and autophagic vacuole formation in senescent endothelial cells[J]. Aging (Albany NY), 2018, 10(10): 2855-2873.
[57] Incalza MA, D’Oria R, Natalicchio A, et al. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases[J]. Vascul Pharmacol, 2018, 100: 1-19.
[58] LIAN D, YUAN H, YIN X, et al.Puerarin inhibits hyperglycemia-induced inter-endothelial junction through suppressing endothelial Nlrp3 inflammasome activation via ROS-dependent oxidative pathway[J]. Phytomedicine, 2019, 55: 310-319.
[59] YIN Y, LI X, SHA X, et al.Early hyperlipidemia promotes endothelial activation via a caspase-1-sirtuin 1 pathway[J]. Arterioscler Thromb Vasc Biol, 2015, 35(4): 804-816.
[60] MENG WY, LI YL, WEN H, et al.Notoginsenoside R1 protects vascular endothelial cells from ox-LDL-induced apoptosis[J]. Zhejiang Medical Journal(浙江医学), 2021, 43(7): 711-715, 809.
[61] JIANG S.Effects of Astragalus polysaccharides on expression of NLRP3 inflammasome in human vascular endothelial cells induced by free fatty acids[J]. Shaanxi Journal of Traditional Chinese Medicine(陕西中医), 2019, 40(9): 1165-1169, 1314.
[62] JIANG SM, ZHANG KJ, ZHOU T, et al.TanshinoneⅡA alleviates human umbilical vein endothelial cell injury by inhibiting oxidative stress[J]. Acta Academiae Medicinae Xuzhou(徐州医科大学学报), 2021, 41(4): 235-240.
[63] QU J, CHENG Y, WU W, et al.Glycocalyx impairment in vascular disease: focus on inflammation[J]. Front Cell Dev Biol, 2021, 9: 730621.
[64] GAI FF, FANG LM, XIE SF, et al.Lycopus lucidus turcz attenuates glomerular endothelial cells injury induced by high glucose via protecting glycocalyx core proteins[J]. Chinese Journal of Integrated Traditional and Western Nephrology(中国中西医结合肾病杂志), 2022, 23(3): 200-203.
[65] YUAN Y.Effects of volatile oil from leek root on endothelial surface layer of human umbilical vein endothelial cells and its mechanism[D]. Lanzhou: Lanzhou University, 2020.
[66] PERNOMIAN L, MOREIRA JD, GOMES MS.In the view of endothelial microparticles: novel perspectives for diagnostic and pharmacological management of cardiovascular risk during diabetes distress[J]. J Diabetes Res, 2018, 2018: 9685205.
[67] LUGO-GAVIDIA LM, BURGER D, MATTHEWS VB, et al.Role of microparticles in cardiovascular disease: implications for endothelial dysfunction, thrombosis, and inflammation[J]. Hypertension, 2021, 77(6): 1825-1844.
[68] HELAL O, DEFOORT C, ROBERT S, et al.Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress[J]. Nutr Metab Cardiovasc Dis, 2011, 21(9): 665-671.
[69] BEREZIN AE, KREMZER AA, BEREZINA TA, et al.The pattern of circulating microparticles in patients with diabetes mellitus with asymptomatic atherosclerosis[J]. Acta Clin Belg, 2016, 71(1): 38-45.
[70] LU YG, FU CH,YAN H, et al.Influence of Tongxinluo on blood endothelial microparticles in patients with hypertension[J]. Chinese Journal of Cardiovascular Rehabilitation Medicine(心血管康复医学杂志), 2012, 21(6): 654-657.
[71] NI YQ, FANG ZH.Effects of sports with different strength combined with traditional Chinese medicine on function of vascular endothelium of IGT Rats[J]. Chinese Journal of Information on Traditional Chinese Medicine(中国中医药信息杂志), 2016, 23(4): 54-57.
[72] DA ROCHA RF, DE BASTIANI MA, KLAMT F.Bioinformatics approach to evaluate differential gene expression of M1/M2 macrophage phenotypes and antioxidant genes in atherosclerosis[J]. Cell Biochem Biophys, 2014, 70(2): 831-839.
[73] CHEN X.Effect and mechanism of Chaiqi decoction on ameliorating vascular endothelial injury in metabolic syndrome by upregulating autophagy[D]. Beijing: Beijing University of Chinese Medicine, 2020.
[74] ZHAO LF, YU HH, TIAN WY.Research progress of traditional Chinese medicine monomer regulating autopha of vascular endothelial cells and interfering atherosclersi[J]. Chinese Archives of Traditional Chinese Medicine(中华中医药学刊), 2021, 39(11): 117-120.
[75] ZHONG Z, LI XP, HU ZX, et al.Efficacy and safety of traditional Chinese medicine in the treatment of metabolic syndrome[J].Chinese Journal of Gerontology(中国老年学杂志), 2015, 35(19): 5517-5518.